Cartesian Therapeutics, Inc.
RNAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001453687
No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Cartesian Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 70 | 1 | 62 | −7 |
| Shares | 54.7M | 1.70K | 3.27M | −51.4M (−94.0%) |
| Value | $35.3M | $1.00K | $88.3M | +$53.0M (+150.3%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| MPM Oncology Impact Management LP | 259,696 | $7.01M | 1.09% |
| Ikarian Capital, LLC | 242,370 | $6.55M | 2.04% |
| Yale University | 100,000 | $2.70M | 77.59% |
| Logos Global Management LP | 90,000 | $2.43M | 0.28% |
| Boothbay Fund Management, LLC | 68,540 | $1.85M | 0.06% |
| Lake Street Advisors Group, LLC | 31,644 | $854.7K | 0.04% |
| Marshall Wace, LLP | 30,038 | $811.3K | 0.00% |
| Cubist Systematic Strategies, LLC | 13,010 | $351.4K | 0.01% |
| Twin Focus Capital Partners, LLC | 10,000 | $270.1K | 0.04% |
| Freestone Capital Holdings, LLC | 8,000 | $216.1K | 0.01% |
| Corebridge Financial, Inc. | 3,888 | $105.0K | 0.00% |
| MetLife Investment Management | 2,838 | $76.7K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 1,824 | $49.3K | 0.01% |
| Point72 (DIFC) Ltd | 1,725 | $46.6K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 1,627 | $43.9K | 0.00% |
| Activest Wealth Management | 66 | $1.78K | 0.00% |
| National Bank of Canada | 40 | $970 | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 3,715 | $669 | 0.00% |
| Nisa Investment Advisors, LLC | 14 | $378 | 0.00% |
| SRS Capital Advisors, Inc. | 12 | $325 | 0.00% |
Sold out (27)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
Not filed for Q2 2024 yet (1)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Cutler Group LP | 1,700 | $1.00K |